Chesney Russell W, Carpenter Myra A, Moxey-Mims Marva, Nyberg Leroy, Greenfield Saul P, Hoberman Alejandro, Keren Ron, Matthews Ron, Matoo Tej K
University of Tennessee Health Science Center, Department of Pediatrics, Memphis, TN 38103, USA.
Pediatrics. 2008 Dec;122 Suppl 5(0 5):S233-9. doi: 10.1542/peds.2008-1285c.
Because of the frequency of urinary tract infections in children, off-label use of antimicrobial prophylaxis is often the usual treatment of children with vesicoureteral reflux, and such use is increasingly being called into question; hence, a definitive study to determine the value of antimicrobial prophylaxis with regard to the recurrence of urinary tract infection and the incidence of renal scarring is essential. The currently recommended follow-up procedures (repeated urine cultures, renal and genitourinary imaging, antimicrobial therapy and prophylaxis, as well as other factors including cleanliness, adequate bladder and bowel emptying, and compliance with protocols) are expensive (in terms of time, attention to detail, and cost) and cumbersome. Such recommendations should be evidence-based.
由于儿童尿路感染的发生率较高,抗菌药物预防性的非标签使用常常是膀胱输尿管反流患儿的常规治疗方法,而这种使用方式越来越受到质疑;因此,开展一项确定性研究以确定抗菌药物预防在尿路感染复发和肾瘢痕形成发生率方面的价值至关重要。目前推荐的随访程序(重复进行尿培养、肾脏和泌尿生殖系统影像学检查、抗菌治疗和预防,以及其他因素,包括清洁、膀胱和肠道充分排空以及遵守方案)既昂贵(在时间、细节关注和成本方面)又繁琐。此类建议应以证据为基础。